Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/2010
08/19/2010WO2010093359A1 Compounds for the treatment of hepatitis c
08/19/2010WO2010093341A1 C-7 isoxazolinyl quinolone/naphthyridine derivatives useful as antibacterial agents
08/19/2010WO2010093245A1 Antimicrobial peptides based on cmap27
08/19/2010WO2010092963A1 Drug transporter, and adjuvant and vaccine each utilizing same
08/19/2010WO2010092015A1 Urea triazololo [1, 5-a] pyridine derivatives as pi3k inhibitors
08/19/2010WO2010091543A1 Novel hydrazino-cyclobut-3-ene-1, 2-dione derivatives as cxcr2 antagonists
08/19/2010WO2010091542A1 Anti-tumor, anti-bacterial and/or anti-viral applications of ctla4ig and derivatives thereof.
08/19/2010WO2010075477A3 Methods of treating or preventing biofilm associated infections with free available chlorine water
08/19/2010WO2010061185A3 Carbonic anhydrase inhibitors for treating dandruff and related disorders
08/19/2010WO2010054858A3 Polyvinylpyrrolidone as a therapeutically active compound for the treatment and prevention of diseases involving bacterial, viral and fungal pathogens
08/19/2010WO2010045281A3 Stable aqueous formulations of water insoluble or poorly soluble drugs
08/19/2010WO2010039534A3 Viral and fungal inhibitors
08/19/2010WO2010033198A3 Analogs of indole-3-carbinol and their use as agents against infection
08/19/2010US20100210838 Fluoropyrrolidines having dipeptidyl peptidase enzyme inhibitory activity
08/19/2010US20100210727 Hepoxilin analog enantiomers
08/19/2010US20100210703 Anti-fungal formulation
08/19/2010US20100210702 Anti-fungal formulation
08/19/2010US20100210685 Novel Substituted Indoles
08/19/2010US20100210677 Novel compound, corresponding compositions, preparation and/or treatment methods
08/19/2010US20100210669 Crystalline form of entecavir, its preparation and the pharmaceutical composition and uses thereof
08/19/2010US20100210646 2-morpholin-4-yl-pyrimidines as pi3k inhibitors
08/19/2010US20100210644 Chemical compounds
08/19/2010US20100210616 Metal complexes incorporated within biodegradable nanoparticles and their use
08/19/2010US20100210603 Novel sulfonamide inhibitors of aspartyl protease
08/19/2010US20100210602 PhoU (PerF), A PERSISTENCE SWITCH INVOLVED IN PERSISTER FORMATION AND TOLERANCE TO MULTIPLE ANTIBIOTICS AND STRESSES AS A DRUG TARGET FOR PERSISTER BACTERIA
08/19/2010US20100210599 Prodrugs of piperazine and substituted piperidine antiviral agents
08/19/2010US20100210597 C21-Deoxy Ansamycin Derivatives as Antitumor Agents
08/19/2010US20100210593 Pyridine- and Pyrimidinecarboxamides as CXCR2 Modulators
08/19/2010US20100210581 Nucleoside Derivatives as Inhibitors of Viral Polymerases
08/19/2010US20100210577 Cyclic carboxylic acid rhodanine derivatives for the treatment and prevention of tuberculosis
08/19/2010US20100210576 Polyene diester antibiotics
08/19/2010US20100210575 Structuring effect of cholesterol in peg-phospholipid micelles, drug delivery of amphotericin b, and combination antifungals
08/19/2010US20100210571 Topical formulations for treatment of skin disorders
08/19/2010US20100210570 Lincomycin derivatives and antimicrobial agents comprising the same as active ingredient
08/19/2010US20100210568 Thyrotropin releasing hormone for therapeutic applications
08/19/2010US20100210567 Use of a tuftsin as a therapeutic agent
08/19/2010US20100210562 Use of il-1 receptor peptide, alone or in combination with d-ala-gln-octadecyl ester, as a therapeutic agent
08/19/2010US20100210561 Use of peptide as a therapeutic agent
08/19/2010US20100210559 Trap-14 as a therapeutic agent
08/19/2010US20100210558 Minigastrin as a therapeutic agent
08/19/2010US20100210557 Use of rfrp, alone or in combination with neurokinin-b, as a therapeutic agent
08/19/2010US20100210556 Use of a peptide as a therapeutic agent
08/19/2010US20100210555 Use of a laminin peptide as a therapeutic agent
08/19/2010US20100210553 Use of the peptide asn-asp-asp-cys-glu- leu-cys-val-asn-val-ala-cys-thr-gly-cys-leu alone or in combination with the peptide thr-thr-ser-gln-val- arg-pro-arg as a therapeutic agent
08/19/2010US20100210540 Use of the peptide combination thymosin beta 4 and delta sleep inducing peptide as a therapeutic agent
08/19/2010US20100210538 Therapeutic uses of intermedin 47 and 53 peptides
08/19/2010US20100210537 Use of a defensin peptide as a therapeutic agent
08/19/2010US20100210536 Use of leptin (22-56 ) as a therapeutic agent
08/19/2010US20100210534 Use of a peptide as a therapeutic agent
08/19/2010US20100210533 Use of urocortin and corticotropin-releasing factor as therapeutic agents
08/19/2010US20100210532 Use of neuropeptide sf, alone or in combination with glp-2, as a therapeutic agent
08/19/2010US20100210528 Compositions, methods and uses for inhibition and/or treatment of influenza infection
08/19/2010US20100210514 RNAi Inhibition of Alpha-ENaC Expression
08/19/2010US20100210513 RNAi Inhibition of Alpha-ENaC Expression
08/19/2010US20100210510 Oral lactoferrin in the treatment of sepsis
08/19/2010US20100210476 Pyrrolo[2,3-b]Pyridine Derivatives Active as Kinase Inhibitors and Pharmaceutical Compositions Comprising Them
08/19/2010US20100209958 Method of treating arthritis and promoting growth of articular chondrocytes
08/19/2010US20100209905 Protein d - an igd-binding protein of haemophilus influenzae
08/19/2010US20100209541 Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
08/19/2010US20100209540 Inhalation formulation for treating and prophylactic use in bacteria, mycobacterial and fungal respiratory infections
08/19/2010US20100209539 Compositions and methods of using same for treatment of a disease or disorder of the eye and/or the adnexa of the eye
08/19/2010US20100209536 Methods and Kits for Use in the Treatment and Prevention of Diseases or Conditions of the Immune System or Infectious Diseases
08/19/2010US20100209535 Method of treating viral conditions
08/19/2010US20100209529 Pharmacologic-functioning water and usage of the same
08/19/2010US20100209528 Storage-stable aqueous solutions of chlorine dioxide and methods for preparing and using them
08/19/2010US20100209526 Product comprising a combination of milk serum apoproteins and free fatty acids
08/19/2010US20100209516 Triggered Drug Release Via Physiologically Responsive Polymers
08/19/2010US20100209507 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
08/19/2010US20100209494 Liposomes and Uses Thereof
08/19/2010US20100209491 Method for enhancing serum stability and lowering immune response of sirna down-regulating gene expression of hbv or hcv
08/19/2010US20100209487 Nicked or gapped nucleic acid molecules and uses thereof
08/19/2010US20100209457 Pneumococcal serotype 6d
08/19/2010US20100209456 Treating neoplasms with neurotoxin
08/19/2010US20100209455 Thermal inactivation of rotavirus
08/19/2010US20100209454 Attenuated viruses useful for vaccines
08/19/2010US20100209453 Circovirus sequence associated with piglet weight loss disease (pwd)
08/19/2010US20100209451 Compositions and Methods Related to Adenovirus Based Delivery of Antigens
08/19/2010US20100209450 Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
08/19/2010US20100209448 Synthetic anti-candida albicans oligosaccharide based vaccines
08/19/2010US20100209446 Ostertagia Vaccine
08/19/2010US20100209442 Deglycosylated and desialidated long pentraxin ptx3
08/19/2010US20100209440 Targeted Delivery of siRNA
08/19/2010US20100209433 Methods for the diagnosis and for the treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists
08/19/2010US20100209411 Use of hydrolytic and oxidative enzymes to dissolve biofilm in ears
08/19/2010US20100209393 Use of Polynucleotides Encoding Small Acid-Soluble Spore Protein for Inhibiting Bacterial Cell Growth and/or Treating Bacterial Infections
08/19/2010US20100209390 Cyclosporin analogues
08/19/2010US20100209384 Sustained release formulations comprising very low molecular weight polymers
08/19/2010US20100209368 Method and preparation for treating baldness
08/19/2010US20100209359 Medicated chewing gum
08/19/2010US20100209349 Phage Therapy Against Pseudomonas Aeruginosa
08/19/2010DE202010006870U1 Salbe zur Behandlung der Mortellaro-Krankheit Ointment for the treatment of hairy wart disease
08/19/2010DE102009009245A1 Composition useful for prevention and treatment of viral infections, preferably influenza, conjunctivitis or cervicitis and secondary infections that are associated with it, comprises an agglutination inhibitor
08/19/2010CA2752033A1 Antibody to cytolethal distending toxin of campylobacter jejuni
08/19/2010CA2752020A1 Antibiotic therapy to reduce the likelihood of developing post-infectious irritable bowel syndrome
08/19/2010CA2751751A1 Compositions comprising reduced genome bacteria for use in treatment of sepsis
08/19/2010CA2751379A1 Influenza vaccines with reduced amounts of squalene
08/19/2010CA2751277A1 Carba-nucleoside analogs for antiviral treatment
08/19/2010CA2750123A1 Methods of using and compositions comprising pde4 modulators for treatment, prevention and management of tuberculosis
08/18/2010EP2218732A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
08/18/2010EP2218731A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
1 ... 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 ... 1798